Sandoz, a Novartis company, is a world leading generics pharmaceuticals company. The company develops, manufactures and markets off-patent medicines, as well as pharmaceutical and biotechnological active ingredients.
Sandoz, with its strong technology base, particularly in the application of �difficult-to-make� generic products (transdermal patches, inhalation products, sustained-release implants and multi-particulate drug-delivery dosage forms), is poised to be a leader in all aspects of generic pharmaceuticals, including bio-pharmaceuticals and anti-infective. This reinforces the Sandoz Vision to go beyond traditional generic products and bring innovative technologies and delivery systems to market, making a world of difference in generics.